Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related Disorders

Overview

Journal Intern Med

Specialty General Medicine

Date 2018 Aug 28

PMID 30146596

Citations 3

Authors

Kosaku Murakami

Tsuneyo Mimori

Affiliations

Soon will be listed here.

Abstract

Connective tissue diseases (CTDs), also known as systemic autoimmune diseases, involve a variety of autoantibodies against cellular components. An important factor regarding these autoantibodies is that each antibody is exclusively related to a certain clinical feature of the disease type, which may prove useful in clinical practice. Thus far, more than 100 types of autoantibodies have been found in CTDs, and most of their target antigens have been identified. Many of these autoantigens are enzymes or regulators involved in important cellular functions, such as gene replication, transcription, repair/recombination, RNA processing, and protein synthesis, as well as proteins that form complexes with RNA and DNA. This article reviews the autoantibodies for each CTD, along with an assessment of their clinical significance, and provides suggestions regarding their utilization for clinical practice.

Citing Articles

Editorial: Etiopathogenesis of Systemic Sclerosis: An Update.

Stifano G, De Palma R Front Immunol. 2021; 12:663381.

PMID: 33828566 PMC: 8019788. DOI: 10.3389/fimmu.2021.663381.

Omega-3 fatty acid intake suppresses induction of diverse autoantibody repertoire by crystalline silica in lupus-prone mice.

Rajasinghe L, Li Q, Zhu C, Yan M, Chauhan P, Wierenga K Autoimmunity. 2020; 53(7):415-433.

PMID: 32903098 PMC: 8020726. DOI: 10.1080/08916934.2020.1801651.

Increased expression of caspase 1 during active phase of connective tissue disease.

Cai R, Wang Q, Zhu G, Zhu L, Tao Z PeerJ. 2019; 7:e7321.

PMID: 31367484 PMC: 6657674. DOI: 10.7717/peerj.7321.

References

Badrising U, van Duinen S, Breedveld F, van Doorn P, Van Engelen B, van den Hoogen F . Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology. 2000; 55(9):1385-7. DOI: 10.1212/wnl.55.9.1385. View

Corrigall V, Bodman-Smith M, Fife M, Canas B, Myers L, Wooley P . The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol. 2001; 166(3):1492-8. DOI: 10.4049/jimmunol.166.3.1492. View

Blass S, Union A, Raymackers J, Schumann F, Ungethum U, de Keyser F . The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum. 2001; 44(4):761-71. DOI: 10.1002/1529-0131(200104)44:4<761::AID-ANR132>3.0.CO;2-S. View

Wang H, Zhang Y . Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor. Nucleic Acids Res. 2001; 29(12):2517-21. PMC: 55739. DOI: 10.1093/nar/29.12.2517. View

Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N . Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma. Rheumatology (Oxford). 2001; 40(6):683-6. DOI: 10.1093/rheumatology/40.6.683. View

Tormey V, Bunn C, Denton C, Black C . Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology (Oxford). 2001; 40(10):1157-62. DOI: 10.1093/rheumatology/40.10.1157. View

Wang J, Satoh M, Kabir F, Shaw M, Domingo M, Mansoor R . Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum. 2001; 44(10):2367-70. DOI: 10.1002/1529-0131(200110)44:10<2367::aid-art400>3.0.co;2-i. View

Goldblatt F, Gordon T, Waterman S . Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology. 2002; 123(4):1144-50. DOI: 10.1053/gast.2002.36057. View

Kao A, Lacomis D, Lucas M, Fertig N, Oddis C . Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum. 2004; 50(1):209-15. DOI: 10.1002/art.11484. View

10.

Kawabata D, Tanaka M, Fujii T, Umehara H, Fujita Y, Yoshifuji H . Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. Arthritis Rheum. 2004; 50(2):660-8. DOI: 10.1002/art.20023. View

11.

Kowal C, DeGiorgio L, Nakaoka T, Hetherington H, Huerta P, Diamond B . Cognition and immunity; antibody impairs memory. Immunity. 2004; 21(2):179-88. DOI: 10.1016/j.immuni.2004.07.011. View

12.

Nagai T, Arinuma Y, Yanagida T, Yamamoto K, Hirohata S . Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes. Arthritis Rheum. 2005; 52(3):847-55. DOI: 10.1002/art.20869. View

13.

Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T . Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005; 52(5):1571-6. DOI: 10.1002/art.21023. View

14.

Steen V . Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005; 35(1):35-42. DOI: 10.1016/j.semarthrit.2005.03.005. View

15.

Yoshifuji H, Umehara H, Maruyama H, Itoh M, Tanaka M, Kawabata D . Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro. Int Immunol. 2005; 17(10):1327-36. DOI: 10.1093/intimm/dxh311. View

16.

Targoff I, Trieu E, Plotz P, Miller F . Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum. 1992; 35(7):821-30. DOI: 10.1002/art.1780350718. View

17.

Hengstman G, ter Laak H, Vree Egberts W, Lundberg I, Moutsopoulos H, Vencovsky J . Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis. 2006; 65(12):1635-8. PMC: 1798474. DOI: 10.1136/ard.2006.052191. View

18.

Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D . Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity. 2006; 39(3):233-41. DOI: 10.1080/08916930600622884. View

19.

Svegliati Baroni S, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M . Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med. 2006; 354(25):2667-76. DOI: 10.1056/NEJMoa052955. View

20.

Lapteva L, Nowak M, Yarboro C, Takada K, Roebuck-Spencer T, Weickert T . Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum. 2006; 54(8):2505-14. DOI: 10.1002/art.22031. View